Pentax, NinePoint Medical & more — 5 GI company key notes

Here are five updates on GI companies from the past week:

Advertisement

Pentax received the German Innovation Award for its DEC duodenoscope’s disposable design elements, as well as an honor from the ESGE Days Congress for its red Density Program, which supports physicians in the endoscopic assessment of ulcerative colitis.

Pentax also published a series of lectures from the “Reducing the risk of infection in ERCP” symposium, which covered the challenges of performing biliopancreatic procedures and reducing the risk of cross contamination in endoscope reprocessing.

NinePoint Medical named Eman Namati, PhD its new CEO. Dr. Namati replaces Christopher von Jako, PhD, who will now serve as an independent board member.

Takeda opened its new headquarters in Tokyo, which will serve as the main office for the company’s worldwide operations.

Takeda’s shareholders voted down a proposal that would’ve required putting major acquisitions to a vote, including the company’s $62 billion acquisition of Shire.

More articles on gastroenterology:

GI leader to know: Dr. Paul Hendrix of Grand Teton Gastroenterology
15 new GI/endoscopy centers for the first half of 2018
How do IBS-C patients’ needs compare with challenges for healthcare providers? 5 insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.